In the PCK rat, a rodent model of Autosomal Recessive Polycystic Kidney Disease (ARPKD), a spontaneous splicing mutation of Pkhd1 initiates hepatic cyst development. Cystic cholangiocytes possess short and malformed cilia that do not express fibrocystin, the Pkhd1 protein. During the disease course, cysts continue to grow; however, the mechanisms underlying cyst progression are unclear due in part to the lack of suitable cell lines to study cystogenesis. Here, we describe the development of a PCK-derived cholangiocyte cell line (PCK-CCL). Normal rat cholangiocytes (NRCs) were used as a control. The PCK-CCL maintained a cholangiocyte phenotype as assessed by the expression of the CK-19, CK-7 and GGT. PCK-CCL grown on collagen formed a polarized monolayer with well-developed junctional complexes, and distinct apical and basolateral membranes. Compared to NRCs, cilia in the PCK-CCL were short and malformed and did not express fibrocystin. The PCK-CCL exhibited a higher rate of proliferation (Po0.05) with a doubling time approximately half that of NRCs. By RT-PCR analysis of exons 33-37, an approximately 800 bp product of Pkhd1 was amplified in NRCs. In contrast and as expected, in the PCK-CCL, the Pkhd1 amplicon was smaller (B630 bp) reflecting the IVS35-2A-T mutation. PCK-CCL and NRCs seeded in 3-D cultures formed cystic structures; however, the PCK cysts expanded progressively up to day 21 while cysts formed by NRCs remained the same size after day 9. In summary, we have developed a cholangiocyte cell line from the PCK rat that retains properties of the cholangiocytes lining hepatic cysts in vivo. The cells have been grown continuously for B18 month and 45 passages without crisis or senescence. The morphology and growth characteristics of the PCK-CCL are consistent with those seen in vivo in the PCK rat, suggesting that this cell line will be useful in dissecting the mechanisms of hepatic cyst formation. Laboratory Investigation (2006) 86, 940-950.
Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a devastating infantile disease with an incidence of 1:20 000 that often results in fetal or neonatal death due to markedly enlarged kidneys, impaired lung function and pulmonary hypoplasia. Liver cysts develop in most babies who survive the perinatal period and, with age, liver cystic disease becomes the major cause of morbidity and mortality. [1] [2] [3] [4] [5] Biliary dysgenesis is characterized by congenital hepatic fibrosis, bile duct dilation and cyst formation. The hepatic cysts are lined by biliary epithelia (ie, cholangiocytes) and increase in number and size throughout life. The gene responsible for ARPKD, PKHD1, encodes a large trans-membrane protein, fibrocystin, whose function is unknown. [6] [7] [8] It has been shown recently by us 9, 10 and others 11, 12 that fibrocystin is expressed in primary cilia of biliary and renal epithelia under normal conditions. Disruption of fibrocystin expression in the PCK rat, an animal model of ARPKD, results in kidney and liver cystogenesis. 9 Despite the identification of the genetic defect that causes this disease, the pathophysiology of cyst formation, growth and expansion is still unclear. It has been suggested that abnorm-alities in cell proliferation, fluid secretion and extracellular matrix biology all contribute to the disease. 1, 2, 13 Various animal models of ARPKD have been developed over time, many of them display distinct liver pathology. [14] [15] [16] Of these models, the PCK rat closely resembles human ARPKD. The gene, Pkhd1, that causes kidney and liver disease in these rats is orthologous to the human PKHD1. 6 We have recently described in detail the morphology of cholangiocytes that line liver cysts in the PCK rat. 17 In particular, we have shown that cysts originate from the intrahepatic bile ducts, and that cystic cholangiocytes have a disease specific phenotype including short and malformed cilia that do not express fibrocystin.
Studies of the mechanisms of liver cyst formation in ARPKD have been limited by the lack of suitable cell lines. Thus, to explore the mechanisms of cyst growth and expansion in ARPKD, our aim was to develop a cholangiocyte cell line derived from the intrahepatic bile ducts of the PCK rat which we designated PCK-CCL (ie, PolyCystic Kidney Cholangiocyte Cell Line). We believe that the PCK-CCL will provide a valuable tool to study the molecular mechanisms underlying cyst development and progression in ARPKD.
Materials and methods

Cell Culture of Primary PCK Cholangiocytes
Biliary explants were isolated from 2-to 3-month old male PCK rats as previously described. 18 Briefly, the livers were perfused with Hepes-buffer saline (140 mM NaCl, 5.4 mM KCl, 0.8 mM Na 2 HPO 4 , 25 mM HEPES, pH 7.4) plus 2 mM CaCl 2 and 0.02% collagenase type II and mechanically disrupted to obtain a clean portal tract residue. They were then placed in a solution of 25 ml of RPMI medium, 10 mg hyaluronidase, 8 mg collagenase type XI, and 6 mg DNase and shaken for 30 min in 371C water bath. These pieces were gravity sedimented and washed with HBS to remove the digestive enzymes. The cells were entered into culture as previously described. 19 Biliary explants were washed three times with DMEM/F12 medium, re-suspended in a large volume of DMEM/F12 and placed in a 10 cm tissue culture dish in order to shed contaminant cells such a fibroblasts. After approximately 2 h the explants were re-suspended in 1.5 ml of type I rat tail collagen (1.5 mg/ml, BD Biosciences, Bedford, MA, USA) supplemented with 10% Matrigel (BD Biosciences, Bedford, MA, USA) and evenly spread in a 35 mm dish previously coated with 1 ml of the collagen mixture. The plates were placed in a tissue culture incubator (371C, 5% CO 2 , and 100% humidity) for 30 min to allow the gel to solidify. Cholangiocyte media was then poured over the gel and the plates were returned to the incubator. The medium was changed every day to avoid possible contamination. Within 2-3 days of culture, the cholangiocytes proliferated and formed cysts. The medium was removed from these dishes and replaced with DMEM/F12 containing 2 mg/ml collagenase type XI (Sigma) and allowed to digest 45 min at 371C. Under an inverted scope in sterile conditions, the cysts were dissected using sterile needles and Pasteur pipets to select areas of cholangiocytes free from fibroblast contamination. The cysts were then washed by gravity sedimentation, lightly trypsinized and seeded on top a thick layer of the rat tail collagen. These cells seeded down and proliferated as monolayers across the majority of the plate.
Immunofluorescence Confocal Microscopy
Cholangiocytes grown on collagen coated cover slips were fixed with ice cold methanol for 30 min and permeabilized for 2 min with 0.2% Triton X 100. After blocking, the cells were incubated overnight at 41C with primary antibodies against CK-7 (1:50, ICN), CK-19 (1:200, Sigma), Vimentin (BioGenex, San Ramon, CA, USA), acetylated apha-tubulin (1:200, Sigma), fibrocystin (gift from Dr Ward), ZO-1 (1:100, Zymed, Carlsbad, CA, USA); Beta-catenin (1:100, BD Biosciences, Bedford, MA, USA). Alexa-488 and Alexa-594 (1:500, Molecular Probes, Carlsbad, CA, USA) was used as a secondary antibody and nuclei were stain with 4 0 ,6-diamidino-2-phenylindole (DAPI). Gamma-glutamyl transpeptidase (GGT) enzyme immuno-histochemical staining was performed on cytospun fractions of the PCK-CCL.
Transmission and Scanning Electron Microscopy
The cell lines were grown to 10 days post-confluence on collagen coated 24-well tissue culture inserts. The cells were fixed in 4% paraformaldehdye/2% gluteraldehyde for 1 h at room temperature or at 41C overnight, then post-fixed for 1 h in 1% osmium tetroxide. For TEM, the samples were dehydrated, embedded in Spurrs resin, sectioned at 80 nm, and observed using a Joel 12 electron microscope (Joel USA Inc., Peabody, MA, USA). SEM samples were dehydrated, dried in a critical point drying device, mounted, sputter coated, and examined with a Hitachi S-4700 microscope (Hitachi Inc., Pleasanton, CA, USA). Scanning micrographs of PCK-CCL and NRCs were used to measure the length of cilia as we previously described. 9 
TEER Measurements
The cells were seeded on Falcon 12-well cell culture inserts (BD Biosciences) previously coated with a thin layer of the collagen/Matrigel mixture. The inserts were monitored each day for confluence and electrical resistance using a Millicel-ERS ohmvoltmeter (Millipore Corporation, Bedford, MA, USA). The TEER values were calculated by converting to O cm 2 .
RNA Isolation and RT-PCR
The cell were grown to confluence in 75 cm 2 flasks, scraped and washed in PBS. RNA was isolated using TRIzol Reagent (Invitrogen). Pkhd1 mRNA was detected by reverse transcription of the RNA to obtain cDNA, followed by polymerase chain reaction using the SuperScript III kit (Invitrogen). The following primers, corresponding to 5 0 and 3 0 regions of the Pkhd1 (forward: TGGTGCTCCGT GCCAAGTC, and reverse: GAGTTCCATTCCCTCA CAGCCAG) were designed and synthesized by Mayo Core Facility. RT-PCR amplification was performed for 35 cycles. Each cycle consisted of denaturation at 941C for 1 min, annealing at 561C for 2 min and extension at 721C for 3 min.
Cell Proliferation Assay
The PCK-CCL and NRCs were seeded at 96-well plate at density 5000 cells/well. The plates were incubated (371C, 5% CO 2 , and 100% humidity) for 48 h prior to the assay. The rate of cell proliferation was determined using CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega).
3-D Culture
The PCK-CCL and NRCs were suspended in 1.5 ml of type I rat tail collagen (1.5 mg/ml, BD Biosciences)
supplemented with 10% Matrigel (BD Biosciences) and poured into 35 mm dish previously pre-coated with 1 ml of the collagen. The collagen gel was allowed to solidify for 20-30 min at room temperature and then overlaid with 1.5 ml of medium, which was replaced every other day. The plates were kept in a tissue culture incubator (371C, 5% CO 2 , and 100% humidity). Development of cystic structures was assessed by light microscopy from 0 to 21 days in culture. Using Image J software (NIH), the outer diameter of each cyst was determined from the average of two perpendicular measurements. The surface area of each cyst was calculated at each time point. The changes in the rate of cyst growth and expansion were expressed as a fold-increase compared to the basal value (day 1).
Results
Development of the PCK-CCL
Bile duct explants were isolated from 2-to 3-month old PCK rats as described in Methods. Small portions of these explants were placed onto a mixture of type I rat tail collagen þ 10% Matrigel. Within 2-3 days, they started to proliferate forming large cysts (Figure 1a ). The cysts were dissected using sterile needles and Pasteur pipets, and again placed on top of a thick collagen layer. After 5-7 days, the cells had spread out from the plated cysts to form the colonies of uniformly sized polygonal cells across the majority of the plate (Figure 1b) . By this time, little fibroblast contamination was apparent. Thus, these colonies were passaged several times in the same manner in order to further reduce contamination with fibroblasts.
Characterization of PCK-CCL
The phenotype of PCK-CCL was determined using a variety of cell-type specific antibodies. The PCK-CCL expressed epithelial cell markers CK-19 (Figure 2a ), CK-7 (Figure 2b ), and GGT ( Figure 2c) ; o2% of the cells were positive for vimentin, a mesenchymal cell marker (Figure 2d) . Thus, the PCK-CCL maintained a cholangiocyte phenotype. We previously reported the establishment of a spontaneously immortalized cholangiocyte cell line derived from normal rats. 19 When grown on appropriate matrices, normal rat cholangiocytes (NRCs) form polarized monolayers with suitable electrical resistance and retain the phenotypic and functional characteristics that define these cells in vivo. Thus, we used NRCs for comparative studies between normal and cystic cholangiocytes. PCK-CCL plated onto a collagen gel spread out as a tight monolayer. Phase-contrast micrograph of the PCK-CCL shows that cholangiocytes were homogenous in size and are polygonal in shape (Figure 3a) . The PCK-CCL expressed the tight and adhesion junction markers, ZO-1 (Figure 3b) and B-catenin (Figure 3c ), respectively. By transmission electron microscopy, the cells had well differentiated morphology with defined apical and basolateral membranes, abundant microvilli, well-developed junctional complexes, and basolaterally located nuclei (Figure 3d and e) . Transepithelial electrical resistance (TEER) in the PCK-CCL was high (Figure 3f ). Figure 4a ) and NRCs (Figure 4c ) grown for 10-14 days under identical conditions revealed that both cell lines developed primary cilia. The result was confirmed by immunofluorescence confocal microscopy (Figure 4b and d) . However, cilia in the PCK-CCL were much shorter than in NRCs: 2.5970.88 mm versus 7.6471.7 mm, respectively (Po0.05; n ¼ 30 for each cell line). By transmission electron microscopy, cilia in the PCK-CCL were malformed (Figure 5a ) as compared to NRCs (Figure 5b ). SEM images demonstrate aberrant cilia in the PCK-CCL with bulbs on the ciliary tip (Figure 5c ). In NRCs primary cilia appear normal (Figure 5d ). The observations made in PCK-CCL are consistent with characteristics of cholangiocyte cilia in liver cysts of the PCK rat that we observed in vivo.
Cilia in the PCK-CCL
SEM of PCK-CCL (
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Expression of Pkhd1 and Fibrocystin in the PCK-CCL By RT-PCR analysis of exons 33-37, an approximately 800 bp product of Pkhd1 was amplified in NRCs and freshly isolated bile ducts from normal rats. In contrast and as expected, in the PCK-CCL and freshly isolated bile ducts from the PCK rat, the Pkhd1 amplicon was smaller (B630 bp) reflecting the IVS35-2A-T mutation ( Figure 6 ). 6 The expression of fibrocystin in PCK-CCL and NRCs was examined by immunofluorescence confocal microscopy. In NRCs fibrocystin was localized in cilia in addition to the cytoplasm and plasma membrane (Figure 7a-c) . In contrast, no fibrocystin was observed in cilia of the PCK-CCL (Figure 7d-f) .
PCK-CCL Growth
Studies of PCK-CCL and NRCs growth were carried out concurrently. The rate of normal and cystic cholangiocytes proliferation was assessed at day 3-7 after the cells were platted. The PCK-CCL showed a higher proliferative response than NRCs; there were statistically significant differences between two cell lines at every time point analyzed (Figure 8 ). The cell doubling time for NRCs and PCK-CCL was 58.1 and 28.8 h, respectively, indicating that the growth rate of the PCK-CCL was accelerated compared to normal cholangiocytes.
PCK-CCL Grown in 3-D Culture
The PCK-CCL and NRCs seeded in 3-D culture organized into cystic structures as assessed by light microscopy. In both cell lines, formation of small cysts was observed within 24-48 h and the cysts continue to grow (Figure 9a ). Cells were maintained in this configuration for up to 3-4 weeks.
Next, we assessed the numbers and size of cystic structures formed by both cell lines in 3-D culture.
We did not find any statistically significant differences in number of PCK-CCL and NRCs cysts over 3 weeks of observations. However, the surface areas of cysts formed by PCK-CCL were substantially larger compared to NRCs. The changes in cystic surface area at day 3, 6, 9, 12, 15 and 21 were compared to Figure 5 Transmission (top) and scanning (bottom) electron microscopy of primary cilia in the PCK-CCL and NRCs. In the PCK-CCL, cilia were abnormal (a) and malformed with bulbs on the ciliary tip (c) compared to cilia in NRCs (c and d). Scale bars: 1 mm (a-c).
initial surface area (at day 1) and expressed as fold increase for each cell line. Quantitation of observed changes are shown in Figure 9b . The cystic structures formed by NRCs grew up to days 3-6, around day 9 they reached the plateau and maintained the same size up to the end of experiment. In contrast, PCK-CCL cysts continue to grow and expand progressively up to day 21.
Discussion
Here, we report the development of cholangiocyte cell line designated PCK-CCL, derived from the intrahepatic bile ducts of the PCK rat, an animal model of Figure 6 RT-PCR analysis of Pkhd1 mRNA expression. Level of Pkhd1 mRNA of expected size was detected in PCK-CCL (B630 bp) and NRCs (B800 bp). Freshly isolated bile ducts from normal (normal BD) and PCK (PCK BD) rats were used as a positive control. ARPKD. The cells have been grown continuously for periods exceeding 18 month and over 45 passages without undergoing crisis or senescence suggesting that they become spontaneously immortalized. The PCK cells exhibit a phenotype of abnormal cholangiocytes which line the liver cysts in the PCK rat in vivo in that they: (i) possess shortened, malformed primary cilia; (ii) express mutated Pkhd1 at the mRNA level; (iii) do not express fibrocystin in cilia.
The PCK-CCL can be grown under different conditions: (i) on a single layer of collagen gel when they form a tight polarized monolayer, and (ii) within a collagen/10% Matrigel matrix (ie, 3-D culture) when they form cystic structures. Both experimental systems (cell monolayer and 3-D culture) will be useful to study the mechanisms of cyst formation and role of different factors (derived from apical or basolateral membranes) that contribute to cyst growth and expansion.
The PCK-CCL displays the epithelial characteristics of cholangiocytes as confirmed by expression of the epithelial cell markers CK-7, CK-19 and GGT. When the cystic cells were seeded at a single layer of collagen gel, they spread out as a tight monolayer with a defined apical and basolateral membranes, well developed microvilli and junctional complexes. The PCK-CCL forms electrically tight monolayers. TEER, which is known to reflect cell density and tight junctional integrity 20 was actually higher in the PCK-CCL compared to NRCs. The PCK-CCL possesses primary cilia on the apical domain. However, compared to NRCs, PCK-CCL cilia were structurally (significantly shorter and malformed) and functionally (they did not express fibrocystin) Figure 9 Cysts formed in 3-D culture by PCK-CCL and NRCs. (a): Cysts began to form within a few hours after the cell were seeded. By day 1, small cysts were observed. Cysts continue to grow and expand over time. Scale bars: 500 mm. (b): Quantitation of the surface area of cysts formed by PCK-CCL (boxes) and NRCs (circles). Area measured at day 1 was considered as initial cystic surface area. Cyst dimensions were measured at day 3, 6, 9, 12, 15 and 21 and corresponding changes were expressed as fold increase compared to initial cystic surface area. *Po0.05 as compared to NRCs, n ¼ 30 (reflects number of cysts measured for each cell line at every time point analyzed).
abnormal. It has been shown previously that the gene, Pkhd1, is responsible for the cystic phenotype in the liver and kidneys of the PCK rat. The disease is a result of a spontaneous splicing mutation IVS35-2A-T. 6 By employing RT-PCR, we showed the differences in the expression of Pkhd1 mRNA between normal and cystic cholangiocytes, further supporting that the PCK-CCL maintains the phenotype seen in vivo. Finally, PCK-derived cholangiocytes proliferate more rapidly than NRCs. All these observations suggest that the cystic phenotype is maintained in established PCK-CCL.
When the PCK cholangiocytes were grown in 3-D culture, they formed spherical cystic structures that expanded in size over time. The 3-D culture system was first established in 1979 using mammary carcinoma tissue. 21, 22 It has been applied widely to many organs and tissue. 23 For example, different kidney epithelial cell lines are known to form spherical cysts within collagen gel. [24] [25] [26] Bile duct epithelial cells and gallbladder-derived cells are also able to form cystic structure in 3-D culture. 23, [27] [28] [29] Thus, The PCK-CCL cultured between two layers of collagen/Matrigel is an excellent model to study cystogenesis in vitro. The 3-D experimental system will allow us to evaluate and test the role of potential factors (activators and inhibitors) that contribute to cyst progression.
Different hormones, growth factors, cytokines (individually or in combination) could promote cyst expansion. Studies of the mechanisms of liver cysts progression in ARPKD have been hampered by the lack of available continuous cyst-derived cell lines. Several investigators have used cyst-derived cells in primary culture. As reported recently by Sato and coauthors, primary culture of bile duct epithelial cells derived from the PCK rat has been employed to study pathogenesis of ARPKD. 30 These cells maintain features of cholangiocytes and had been passaged four times, however, the further fate of these cells in culture is unknown.
Our spontaneously immortalized PCK-CCL derived from the biliary tree of an animal model of APRKD will provide a useful an in vitro system to study the mechanisms of cyst growth and expansion. Having in our disposition two cell lines (one with normal and one with disease phenotype), that can be grown in a single gel (forming monolayer) or in 3-D culture (forming cysts) will help to dissect the differences in cellular response by normal and cystic cholangiocytes to many factors and stimuli involved in cell proliferation, secretion and cellmatrix interactions, processes that underlying liver cystogenesis.
